Reihsaus E, Innis M, MacIntyre N, Liggett SB.

Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and. Small KM, Wagoner LE, Levin AM, Kardia SL, Liggett SB. Polymorphism in the 5′-leader cistron of the beta2-adrenergic receptor gene associated with obesity and type 2 diabetes. Yamada K, Ishiyama-Shigemoto S, Ichikawa F, Yuan X, Koyanagi A, Koyama W et al. Characterization of a unique genetic variant in the beta1-adrenoceptor gene and evaluation of its role in idiopathic dilated cardiomyopathy. Tesson F, Charron P, Peuchmaurd M, Nicaud V, Cambien F, Tiret L et al. Polymorphism in the beta(1)-adrenergic receptor gene and hypertension. Hypertension 2001 37: 1303–1308.īengtsson K, Melander O, Orho-Melander M, Lindblad U, Ranstam J, Rastam L et al. Beta(2)-adrenergic receptor gene variation and hypertension in subjects with type 2 diabetes. Eur Heart J 2000 21: 1853–1858.īengtsson K, Orho-Melander M, Melander O, Lindblad U, Ranstam J, Rastam L et al. A novel polymorphism in the gene coding for the beta(1)-adrenergic receptor associated with survival in patients with heart failure. Beta1-adrenoceptor gene variations: a role in idiopathic dilated cardiomyopathy? J Mol Med 2000 78: 87–93.īorjesson M, Magnusson Y, Hjalmarson A, Andersson B. Podlowski S, Wenzel K, Luther HP, Muller J, Bramlage P, Baumann G et al. Racial differences in the frequencies of cardiac beta(1)-adrenergic receptor polymorphisms: analysis of c145A>G and c1165G>C. Moore JD, Mason DA, Green SA, Hsu J, Liggett SB. The expanding spectrum of G protein diseases.

beta-Adrenergic receptor polymorphisms: cardiovascular disease associations and pharmacogenetics. The promoter and intron/exon structure of the human and mouse beta 3-adrenergic-receptor genes. Van Spronsen A, Nahmias C, Krief S, Briend-Sutren MM, Strosberg AD, Emorine LJ. Rodent and human beta 3-adrenergic receptor genes contain an intron within the protein-coding block. Molecular cloning of a human beta 3-adrenergic receptor cDNA. Lelias JM, Kaghad M, Rodriguez M, Chalon P, Bonnin J, Dupre I et al. The emerging pharmacogenomics of the beta-adrenergic receptors. The negative inotropic action of catecholamines: role of beta3-adrenoceptors. Gauthier C, Leblais V, Moniotte S, Langin D, Balligand JL. Beta3-adrenoceptors in the cardiovascular system. The pharmacologic approach to the treatment of obesity. Weiser M, Frishman WH, Michaelson MD, Abdeen MA. Lack of relationship in type 2 diabetic patients. Beta 3-adrenoreceptor gene polymorphism and leptin. Vendrell J, Gutierrez C, Broch M, Fernandez-Real JM, Aguilar C, Richart C. Association of Trp64Arg beta 3-adrenergic-receptor gene polymorphism with essential hypertension in the Sardinian population. Tonolo G, Melis MG, Secchi G, Atzeni MM, Angius MF, Carboni A et al. Adrenergic nervous system in heart failure. J Am Coll Cardiol 1993 22(4 Suppl A): 61A–71A.Įsler M, Kaye D, Lambert G, Esler D, Jennings G. Changes in myocardial and vascular receptors in heart failure. Altered beta-adrenergic receptor gene regulation and signaling in chronic heart failure. Hurst's The Heart, 11th edn McGraw-Hill: New York, 2004. Am J Respir Crit Care Med 2002 165: 861–866.įuster V, Wayne A, O'Rourke R (eds). Palmer LJ, Silverman ES, Weiss ST, Drazen JM. Genomic approaches to understanding asthma. Familial aggregation and heritability of asthma-associated quantitative traits in a population-based sample of nuclear families. Palmer LJ, Burton PR, James AL, Musk AW, Cookson WO. Future research directions in asthma: an NHLBI Working Group report. Busse W, Banks-Schlegel S, Noel P, Ortega H, Taggart V, Elias J.

Humankind beta